Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade.

J Immunother Cancer · 2022 · PMC9772729 · PMID 36600664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

An overall trend of significantly improved clinical benefits was observed in patients with higher serum albumin levels ( figure 3A–B ).

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.